Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: Evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 73, Issue 12, 2014, Pages 2087-2093

  Minier, Tünde ^a   Guiducci, Serena ^b   Bellando Randone, Silvia ^b   Bruni, Cosimo ^b   Lepri, Gemma ^b   Czirják, László ^a   Distler, Oliver ^c   Walker, Ulrich A ^d   Fransen, Jaap ^e   Allanore, Yannick ^f   Denton, Christopher ^g   Cutolo, Maurizio ^h   Tyndall, Alan ^d   Müller Ladner, Ulf ⁱ   Matucci Cerinic, Marco ^b   Airò, Paolo ^j   Zingarelli, Stefania ^j   Ananieva, Lidia ^j   Desinova, Oxana ^j   Ancuta, Codrina Mihaela ^j   Belibou, Codruta Iulia ^j   Avouac, Jerome ^j   Becvar, Radim ^j   Skacelova, Simona ^j   Beretta, Lorenzo ^j   Vigone, Barbara ^j   Caramaschi, Paola ^j   Sabbagh, Dania ^j   Carpentier, Patrick ^j   Damjanov, Nemanja ^j   Simic Pasalic, Katarina ^j   Distler, Jorg H W ^j   Farge Bancel, Dominique ^j   Hadj Khelifa, Sondess ^j   Foti, Rosario ^j   Di Gangi, Marcella ^j   De La Pena Lefebvre, Paloma Garcia ^j   Hachulla, Eric ^j   Salvador, Maria Joao ^j   Kayser, Cristiane ^j   Camargo, Cintia Zumstein ^j   Kumánovics, Gábor ^j   Li, Mengtao ^j   Xu, Dong ^j   Marasini, Bianca ^j   Belloli, Laura ^j   Maurer, Britta ^j   Mayer, Miroslav ^j   Mihai, Carina ^k   Gherghe, Ana Maria ^k   Riccieri, Valeria ^j   Stefanantoni, Katia ^j   Salsano, Felice ^j   Rosato, Edoardo ^j   Senecal, Jean Luc ^j   Koenig, Martial ^j   Senet, Patricia ^j   Frances, Camille ^j   Sipek, Alenka ^j   Stankovic, Aleksandra ^j   Stamenkovic, Bojana ^j   Smith, Vanessa ^j   Tarner, Ingo H ^j   Wiland, Piotr ^j   more..

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ JUSTUS LIEBIG UNIVERSITY   (Germany)

^j NONE   (Poland)

^k Center For Logic History and the Philosophy of Science Faculty of Philosophy University of Bucharest   (Hungary)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ANGIOSCOPY; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; EARLY DIAGNOSIS; FEMALE; FINGER; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; SKIN ULCER; TELANGIECTASIS; VASCULARIZATION;

ADULT; ANTIBODIES, ANTINUCLEAR; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; FINGERS; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; SKIN ULCER; TELANGIECTASIS;

EID: 84920951755     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203716     Document Type: Article

References (25)

1. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
2. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
3. Valentini G, Cuomo G, Abignano G, et al. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford) 2011;50:317-23.
4. Valentini G, Vettori S, Cuomo G, et al. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther 2012;14:R188.
5. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2-10.
6. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
7. Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
8. Komocsi A, Vorobcsuk A, Faludi R, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2012;51:1027-36.
9. Elhai M, Meune C, Avouac J, et al. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2012;51:1017-26.
10. Matucci-Cerinic M, Allanore Y, Czirjak L, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009;68:1377-80.
11. Avouac J, Fransen J, Walker UA, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011;70:476-81.
12. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
13. Luggen M, Belhorn L, Evans T, et al. The evolution of Raynaud's phenomenon: a longterm prospective study. J Rheumatol 1995;22:2226-32.
14. van den Hoogen F, Khanna D, Fransen J, et al. Classification Criteria for Systemic Sclerosis: An ACR-EULAR Collaborative Initiative. Arthritis Rheum 2013; in press.
15. Gerbracht DD, Steen VD, Ziegler GL, et al. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 1985;28:87-92.
16. Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am 1990;16:11-30.
17. Vayssairat M, Baudot N, Gaitz JP. Raynaud's phenomenon together with antinuclear antibodies: a common subset of incomplete connective tissue disease. J Am Acad Dermatol 1995;32:747-9.
18. Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud 's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-12.
19. Clements P, Lachenbruch P, Siebold J, et al. Inter and intraobserver variability of total skin thickness score (modi fied Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
20. Cutolo M, Sulli A, Pizzorni C, et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
21. Matucci-Cerinic M, Bellando-Randone S, Lepri G, et al. Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. Ann Rheum Dis 2012;72:319-21.
22. Lonzetti LS, Joyal F, Raynauld JP, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
23. Fransen J, Johnson SR, van den Hoogen F, et al. Items for developing revised classifi cation criteria in systemic sclerosis: results of a consensus exercise. Arthritis Care Res (Hoboken) 2012;64:351-7.
24. Johnson SR, Fransen J, Khanna D, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) 2012;64:358-67.
25. Hudson M, Fritzler MJ, Baron M. Systemic sclerosis: establishing diagnostic criteria. Medicine (Baltimore) 2010;89:159-65.